HPV status may affect risk of early death in patients with oropharynx cancer

byWileyElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainNew research indicates that there is a higher risk of early death

Updated on: December 22,2023

HPV status may affect risk of early death in patients with oropharynx cancer

byWileyElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainNew research indicates that there is a higher risk of early death

Updated on:December 22,2023

Blood-clotting protein and blood platelets promote immune evasion, cancer progression

byOhio State University Medical CenterCredit: CC0 Public DomainA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard

Updated on: December 20,2023

Blood-clotting protein and blood platelets promote immune evasion, cancer progression

byOhio State University Medical CenterCredit: CC0 Public DomainA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard

Updated on:December 20,2023

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T

Updated on: December 26,2023

Exposing cancers to bacteria reminds first responder immune cells which side they're on

byGarvan InstituteCancer cells (green) being attacked by neutrophils (red) in the collagen structure (blue) of a tumour’s microenvironment. Credit: Jacqueline Bailey / Dr Chtanova's Innate T

Updated on:December 26,2023

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Updated on: December 26,2023

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Updated on:December 26,2023

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Updated on: December 22,2023

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Updated on:December 22,2023

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on: August 27,2024

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on:August 27,2024

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin

Updated on: December 25,2023

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin

Updated on:December 25,2023

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024

World-first treatment with 'acoustic cluster therapy' to improve chemotherapy delivery

byInstitute of Cancer ResearchCredit: CC0 Public DomainThe first patient has been treated with an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhan

Updated on: December 23,2023

World-first treatment with 'acoustic cluster therapy' to improve chemotherapy delivery

byInstitute of Cancer ResearchCredit: CC0 Public DomainThe first patient has been treated with an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhan

Updated on:December 23,2023

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Updated on: December 22,2023

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Updated on:December 22,2023

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on: July 17,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on:July 17,2024

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Updated on: January 09,2024

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Updated on:January 09,2024